Axsome Therapeutics AXSM Gain Loss From Lease Modification
Gain Loss From Lease Modification at other companies
Other financials
Where this comes from
Reported directly by Axsome Therapeutics in its filing.
Tagged under the XBRL concept axsm:GainLossFromLeaseModification.
The official record: Axsome Therapeutics’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Axsome Therapeutics's gain loss from lease modification.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Axsome Therapeutics's gain loss from lease modification?
- Axsome Therapeutics (AXSM) reported gain loss from lease modification of $2.25M in Q1 2025.
- What does gain loss from lease modification mean?
- The financial impact of changing terms in existing lease contracts.
- How do you interpret gain loss from lease modification?
- Reflects management's ability to optimize real estate or equipment footprints relative to operational needs.
- How does gain loss from lease modification compare across companies?
- Standard for companies with significant real estate or equipment lease portfolios.